These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3175393)

  • 1. Correcting for the bias caused by drop-outs in hypertension trials.
    Murray GD; Findlay JG
    Stat Med; 1988 Sep; 7(9):941-6. PubMed ID: 3175393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketanserin in the treatment of essential hypertension. A double-blind study against metoprolol and a further long-term open treatment.
    Milei J; Lemus J; Bernardiner E
    Acta Cardiol; 1986; 41(6):427-41. PubMed ID: 3544622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of ketanserin and metoprolol in essential hypertension.
    Seedat YK; Parag KB
    S Afr Med J; 1985 Oct; 68(8):555-8. PubMed ID: 2931840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketanserin in the treatment of essential hypertension. A double blind trial against metoprolol followed by one-year open treatment.
    Milei J; Lemus J; Finkielman S; Nahmod VE; Bernardiner E
    Clin Exp Hypertens A; 1989; 11(3):371-89. PubMed ID: 2663239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of chronic antihypertensive treatment with ketanserin versus metoprolol on blood pressure and large arteries' compliance in humans: a cross-over double-blind study.
    De Luca N; Rosiello G; Crispino M; Volpe M; Galletti P; Buzzetti G; Trimarco B
    J Clin Pharmacol; 1988 Apr; 28(4):332-8. PubMed ID: 3292598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind, randomized, cross-over clinical trial of metoprolol and propranolol in mild to moderate essential hypertension.
    Pandhi P; Sahai J; Wahi PL; Sharma BK; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):163-5. PubMed ID: 3549583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term safety and efficacy of ketanserin in essential hypertension: ketanserin versus or in combination with metoprolol.
    Mauersberger H
    J Hypertens Suppl; 1986 Apr; 4(1):S73-5. PubMed ID: 2939217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prolonged treatment with ketanserin in essential hypertension and comparison with metoprolol].
    Finkielman S
    Medicina (B Aires); 1985; 45(4):447-9. PubMed ID: 3916016
    [No Abstract]   [Full Text] [Related]  

  • 9. Ketanserin versus propranolol in the treatment of mild and moderate essential hypertension: corroboration with ambulatory blood pressure monitoring.
    Novo S; Alaimo G; Giordano U; Raineri A; Strano A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S104-6. PubMed ID: 2446055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diltiazem in the treatment of mild or moderate essential hypertension. Comparison with metoprolol in a crossover double-blind trial.
    Trimarco B; DeLuca N; Ricciardelli B; Volpe M; Veniero A; Cuocolo A; Cicala M
    J Clin Pharmacol; 1984; 24(5-6):218-27. PubMed ID: 6378988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketanserin in mild to moderate hypertension in the elderly: a double-blind study versus methyldopa.
    Cattin L; Da Col PG
    Clin Ther; 1989; 11(3):363-72. PubMed ID: 2663164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of ketanserin and metoprolol in the treatment of essential hypertension.
    Sheps SG; Schirger A; Zachariah PK; Fisher LD; Spiekerman RE; Araas FJ; Collins JB; Agerter DC
    Arch Intern Med; 1987 Feb; 147(2):291-6. PubMed ID: 3545116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind comparison of ketanserin with placebo in patients with essential hypertension.
    Wellens D; Peeters G; Baeten B; Sieben G; Symoens J
    Angiology; 1986 Nov; 37(11):810-7. PubMed ID: 3538945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study with the competitive 5-HT2-serotonergic antagonist ketanserin.
    Ferrara LA; Fasano ML; Rubba P; Soro S; Marotta G; Mancini M
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S159-60. PubMed ID: 2412041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the antihypertensive effect of urapidil and metoprolol in hypertension.
    Leonetti G; Mazzola C; Boni S; Guffanti E; Meani A; Zanchetti A
    Eur J Clin Pharmacol; 1986; 30(6):637-40. PubMed ID: 3533561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of ketanserin with captopril in older hypertensives. A double-blind randomised trial.
    Meyer P; Safar M
    Drugs; 1988; 36 Suppl 1():144-7. PubMed ID: 3071458
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hypotensive effect of ketanserin and evaluation of its alpha-blocking activity].
    Casiglia E; Gava R; Nicolin P; Semplicini A; Rossi GP; Buzzaccarini F; Pessina AC; Dal Palù C
    Cardiologia; 1986 Sep; 31(9):709-14. PubMed ID: 3028631
    [No Abstract]   [Full Text] [Related]  

  • 18. Ketanserin, hypertension, and chronic alcoholism: double-blind study in forty patients.
    de Lorenzo A; Ceccanti M; Assogna G; Romeo M; Cavaleri G; Attilia ML
    Int J Clin Pharmacol Res; 1988; 8(5):321-5. PubMed ID: 3068159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of ketanserin and metoprolol in essential hypertension.
    Kane JA; Tooley M; Sibbald B; Gould SE
    J Hypertens Suppl; 1986 Apr; 4(1):S63-5. PubMed ID: 2939215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative trial of ketanserin or bendrofluazide as add-on therapy in hypertensive patients uncontrolled on a beta-blocker alone.
    Korlipara K; Gould SE; Taylor NA; Chandler TC
    Drugs; 1988; 36 Suppl 1():130-4. PubMed ID: 3071456
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.